
çŒåœ¢æå€ç§å»ã§ããçŒç§å°éå»ãå»åŠå士ã ããšããšç¥çµçŒç§å»ð§ âçŒçª©è «çãç²ç¶è ºçŒçãæåŸãŸã§æ²»çã§ããããã«ãªãããâæç¥ã§çŒåœ¢æã®ä¿®è¡âçŸåšå€§éªã§æŽ»åäžð¥ãçŒçŒäžåããããŸã€ããé¡é¢ç¥çµéº»çºã®å建ãããçŒçŒæªæ§è «çãçŒçª©è «çãçŒçª©æžå§è¡ããããŒã¢ãŠã骚æãæ¶å錻è å»åè¡ãŸã§å šéšãã£ãŠãŸãã
Joined August 2020
- Tweets5.1K
- Following854
- Followers6.7K
- Likes38.9K
è¬æŒçšã«RAPDïŒlative Afferent Pupillary DefectïŒã®åç»ãäœããŸãããèäœæš©ããªãŒã«ããŠãããŸãã®ã§ããæŽ»çšãã ããïŒ
ã¢ã«ããã¢ãªããäœå幎ããŸããããã
éã«ãããšäººé¡å
šè¬ã«ç¥çäœæ¥ã«å¯Ÿãã究極çãªã¹ãã€ãã¯ããèŠæ±ãããæä»£ã«ãªãã€ã€ãããç®ç«ããªããèªããããªããå²ãããªãâŠããã§ãäœãã奜ãã§ããããã⊠ã¿ãããªããšããããåãããŠãã
å·±ã®å
åŽããã ãæ¥œãããšå¥œããçã¿åºãããâŠã¿ãããªã
7
2,190
æè¿ã®Claude Opusåã¯ãé¢é£å»åŠè«æãæ¢ãããã«ãé¡ããããšãããã®çäŸæ°ã§ã¯æ€åºåãè¶³ããªããŠäœãèšããªãããšããã¢ãã¹ããšæ¬æã®çäŸæ°ãé£ãéã£ãŠããããšãæ®éã«æ»èªãå§ããã®ã§ãçµæ§å匷ã«ãªãð
ãã¯ãã«åç»ãå
¥ãããšãã100MBãè¶
ããã
ããã§Claudeã«ãèŠãç®ãå€ãããªãããã«ãªãµã€ãºããŠããšæããããã¹ã©ã€ãäžã§å®éã«è²ŒãããŠãã倧ããã«åãããŠåç»ãç»åãæé©åããŠãããŠããµã€ãºã1/4以äžã«ãèŠãç®ã¯æ¬åœã«åãã
ããŒããã£ã¹ã¯ã®å®¹éãäžè¶³ããã¡ãªã®ã§ããã¯å©ãã
Claude Codeã§ã®è«ææ ¡æ£ãæè¿ã¯ç®èŠçšããªã³ãã¢ãŠããæå±å
ã«åºãç¢ºèªæžã®èšèŒãŸã§èªååã§ããããã«ãªã£ãããã¹ãéãããããã§ã¹ããããæç€ºããŠããã°ãçãé ã«ã¯ããå·ãäžãã£ãŠããŠãŸãã§ãã¯ãã®ã¢ãã€ã«ãªãŒããŒã®ãããéçšãå·»ãåã£ãŠãããã®ã¯æ¬åœã«å©ããã
çŒæ¿åã«åãäžãã£ãŠããŠéçŒåœ¢æãéªéããŠããæçåèèªãåãããããã§ã¯ïŒãšæããªã©ã
åæ²¡æ³ã§ããŸã¶ãã®èèªåãããã€ãããšåãã«ãããªãã®ãã
TCBæ±äº¬äžå€®çŸå®¹å€ç§ã®ç ç©¶ã°ã«ãŒããã2020幎10ã12æã®2ç¹å没æ³2,934äŸããã以äžãæœåºããŸããã
åæè¡çã¯ã
ã»è±èããïŒ17.0ïŒ
ïŒ32ïŒ188äŸïŒ
ã»è±èãªãïŒ33.5ïŒ
ïŒ63ïŒ188äŸïŒ
è±è䜵çšçŸ€ã§ææã«äœããå¹Žéœ¢ã»æ§å¥ã調æŽããŠãåæ§ã®é¢é£ããããŸããã
èè
ãã¯çŒçª©èèªãåé€ããããšã§ã
ã»è¡åŸæµ®è
«ãéããã«è»œæžããçµç¹ã®å®å®åãæ©ãŸãå¯èœ
ã»è±èæã®å°åéãå¥é¢ã«ããç·ç¶åã»ççãå ããå¯èœæ§
ãæããŠããŸãã
â»è±èã¯çŽ2mmã®å°åéãããçŒçª©èèªãæ§ããã«åé€ããæ¹æ³ã§ãã
äžçŒçŒé¥å¹ãäºå®å€ç·ãªã©ãã®ä»ã®å䜵çã«å¯Ÿããåæè¡ã«ã€ããŠã¯è©äŸ¡ãããŠãããŸããã
ãŸãè±èã®æç¡ã¯ç¡äœçºå²ä»ã§ã¯ãªãè¡è
倿ããŸã¶ãã®åãã»äºéå¹
ã»è¡è
çµéšãªã©ã¯èª¿æŽãããŠããŸããã
11
3,548
ã¢ãã¬ããç¹çŒããããŒãŠãŒã¶ãŒã®å£°ã
ð©ãç¹çŒåŸ1æéãããã¯ç®ã®çã¿ãæ¶ããŠã¹ãããªããããã®åŸãç¹ãåãããçããªã£ãŠããŠã次ã®ç¹çŒã¿ã€ãã³ã°ãŸã§ã¯ä»ã®ç¹çŒã䜿ã£ãŠèããŠããã
ãããŸã§è§£å床ã®é«ãäœ¿çšæã¯åããŠèããã
ã©ããªãŒðçŒåœ¢æå€ç§å» retweeted
ãè«æãæžãã®ã«ãChatGPTãClaudeã¯ã©ããŸã§äœ¿ã£ãŠããã®ïŒã
ååããããèããããã®è³ªåã«ãå»åŠçããããžã£ãŒãã«ã®JAMAãçããåºããŠããŸããïŒ2026幎8ææŽæ°ïŒã
ãã®èšäºã§
ð¥äžçªåèã«ãªã£ããã®ã¯âAcknowledgmentsã®æžãæ¹
ð¥åœ±é¿ã倧ããããªãã®ã¯
âåèæç®ã§ã®AI䜿çšã®éæšå¥šå
ã§ãïŒ
ããAIããã£ãã䜿ãæä»£ã§ã¯ãªããæ£ããé瀺ããŠå ã
ãšäœ¿ãæä»£ã§ãðŽââ ïž
äžåºŠç®ãéãããšãããããããŸãðª
以äžãèŠç¹ããŸãšããŸããð
ã»äœ¿ã£ãŠããïŒ
ç ç©¶ãžã®æŽ»çšãæç®æ€çŽ¢ãåçš¿äœæã®æ¯æŽã翻蚳ãå³è¡šã¥ããããã ãã䜿ã£ãããšã®é瀺ããæ¡ä»¶ã§ããææ³ã»ã¹ãã«ãã§ãã¯ã ãã¯é瀺ããäžèŠã
ã»ãã¡ïŒæ»èªã§ã®AIå©çšïŒæªçºè¡šã®åçš¿ãå€éšAIã«å
¥ããã®ã¯æ©å¯æ§ã®éåïŒãæèŠè«æãã¬ã¿ãŒã®äžæžããCTã»è¡äžåçãªã©èšåºç»åã®çæã»å å·¥ã
(æè¡ã·ã§ãŒãã«ã€ããŠã¯noteæ¬æã§)
ã»éæšå¥šïŒåèæç®ã¥ãããAIã«ä»»ããããšãå®åšããªãè«æãåŒçšããŠããŸãããã«ã·ããŒã·ã§ã³åŒçšããå®éã«å€çºããŠããŠãJAMAã¯æç®ç®¡çã«ã¯Zoteroã»EndNoteãªã©å°çšããŒã«ã®äœ¿çšãå§ããŠããŸã
âïžé瀺ã®ä»æ¹âïž
ããŒã«åã»ããŒãžã§ã³ã»éçºå
ã»äœ¿çšæ¥ã»äœ¿ãæ¹ã»è²¬ä»»ã®æèšãã®6é
ç®ãAcknowledgmentã«æžããŸããèšäºã«ã¯ããã®ãŸãŸã³ããããŠæžãæããããè±æã®æäŸãèŒããŸããã
詳ããã¯noteèšäºã§ãå³è§£ãšæäŸã€ãã§æŽçããŠããŸãïŒ
note.com/yokubari_dr884/n/nbâŠ
ð¬ Editorial by JAMA Executive Managing Editor Annette Flanagin, RN, MA, @JAMAplusAI Editor in Chief, Roy Perlis, MD, MSc, JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS:
Updated JAMA Network guidance on use of #AI in medical publication permits some uses by authors with disclosure, including manuscript preparation, translation, literature search, and research reporting, while reaffirming that authors are responsible for the accuracy and integrity of all submitted content.
The guidance does not permit use of #AI to draft Opinion manuscripts, Letters to the Editor, or online Comments.
ð Read the editorial: ja.ma/4c8dTHg
ããã¯ãšãŠãåæã§ããç¿æ¥ã®CTãèŠãã®ããã€ãæã
ãæ¥ãããã話ã§ãããçŒçª©å¹ãæãã®æè¡ãããæã¯æ¯åæãã§ããç®ãåããªãã£ãããèŠç¥çµé害ã®ãªã¹ã¯ãããã®ã§ããªã®ã§æ¯åæããå
æããããŠãã£ãšããåºæ¥ãªãããšããããšãèããŠããŸããæ¯åæè¡ãããããªããšããæ°æã¡ãšæŠã£ãŠããŸããæ£è
ãããããæè¡ããããªããããããªã
1
15
4,415
ããã¯å²ãšãã®éãã§ã ãšæããLLMã«è«æå·çãæäŒã£ãŠããããšãã¯ã以äžã培åºããŠããã
1ïžâ£ã€ã³ããã®ãåããã¯ãã£ãããšèªã¿çŽããŠç£šãäžãã
2ïžâ£åãã®çåããªã¶ã«ãã§ååã§ããŠãããã確èª
3ïžâ£æåºŠè§£æãšãèšãåºãããæ¬åœã«å¿
èŠããèã
è«æã®æ»èªãããŠãããšãããã¯LLMã«ã¢ã€ãã¢ãèãããã ãããªãã£ãŠãããã
ã»åæ©ãäŒãã£ãŠããªã
ã»ãµã³ãã«ãµã€ãºãå°ãã
ã»çµ±èšãè€é
ã»ä»®èª¬ã«å¯ŸããŠé©åã«æ€èšŒããŠããªã
ã»ããããããã§çŠç¹ãçµããŠããªã
倧äœãããªæãã§ãããã
14
5,040
æ¶éå
èŠé¡ã§èгå¯ãããšãæ¶å°ç®¡ã錻æ¶ç®¡ã®èµ°è¡ãéå¡åºŠåãã¯äººã«ããæ§ã
ã§ããããªã®å
èŠé¡ããªããšç¡çïŒãšãããããªçäŸãããã
æ¶éå
èŠé¡ãããªãã§è¡åŸæçžŸãåçã ã£ããšããå ±åããããã©ãã»ããšããªããšæãð€ð€
1
13
1,979
ç ç©¶è²»ã®ç³è«æžã«LLMã䜿ãã®ã¯ããã¯ãã¢ããã³ããŒãžã§ã¯ãªãè¶³åãã ãšæããæ»èªããåŽããããããã£ãã䜿ã£ãŠããããLLMã«èŠæããçšåºŠã®èšç»ã®ç©Žã¯ã確å®ã«æžç¹å¯Ÿè±¡ã«ãªããAI for Scienceå¿åã®å
šåœ1äžäººã¯çµ¶å¯Ÿã«ãããããLLMã䜿ãã䜿ããªãéžæè¢ã¯ããç¡ãã
ã©ããã£ãŠäœ¿ãããšãããšãç ç©¶æŠèŠãšåºå圢åŒãå
¥åããäžè¶³ããæ
å ±ãèããŠãããã€ã€åããã
åºå圢åŒã®ã³ã³ããã¹ãã¯è§£å床ãé«ãæ¹ãè¯ãããã®ããã«ãŸãšããŠãããããµã€ãã¯ç¥ã
scienceandtechnology.jp/archâŠ
5
851
ã©ããªãŒðçŒåœ¢æå€ç§å» retweeted
ã¢ããããŒã¯ãåŠæ¹ããŠããã£ãããš
â ãªãã³ãæããŠçŒçŒäžåã匷ããªã人ã¯ã»ãŒçŒç²Ÿç²åŽãæ¹å
â¡ç·æ§ã®æ¹ãåã¶
â¢ããŒãã³ã³ã¿ã¯ãçŒçŒäžåã¯ä»ã®ãšããå
šå¡äžãã£ãŠã
ãŸã ãŸã æ°ããããšãããããã
#京æ©ããã¥ã¡çŒç§
#çŒçŒäžåã#ã¢ããããŒã¯
é«ç¥ã§è¡ãããæ¥æ¬çŒåœ¢æå建å€ç§åŠäŒããã®ãããå匷ã«ãªããŸããðïŒ
1
39
2,748
ååã¯åã£ãŠããã©ãçœå
éã飲ããµããªã§é²ãããšãããšããã³ã¹ããªãã®ã§éä¿¡ããªãããã«æ³šæã2000幎åé ããå€ãã®RCTãè¡ãããã«ãã€ã³ãVitCãEãçœå
éãææã«æå¶ã§ããªãã£ãããããCåå€ã¯éã«ãªã¹ã¯ãäžãããšãããŠãããããã§
ãã¶ãäžçå¿ããªã話ã
çœå
éã«ãªã£ãæ¯ãšäžç·ã«çŒç§ãžè¡ã£ããšããå»åž«ã«ãç®ã£ãŠããµã³ã°ã©ã¹ããŠç®è¬ãããŠããã°æªããªãã®ãé²ãããã§ããïŒãã£ãŠèããã
ããŸãããã§ããã§ãããã¿ãããªçããæåŸ
ããŠããã ãã©ãè¿ã£ãŠããäžèšã«èçããŸããšããã
ã¡ãªã¿ã«ãšããã³ã¹ãããã®ã¯ãé£åããã®æ 逿åãVitBãCãEãã«ãã€ã³ãšãã«ç¢ºåºããçœå
éé²è¡æå¶å¹æãå ±åãããŠããããã ããé£åã«å«ãŸããä»ã®ãã£ãã±ãã«ã«ã®ãé°ãªã®ããå¥åº·çãªç掻ã®äººãæå®³ãªãã®ãæåããŠããªãããšã«èµ·å ããã®ãã¯ããŸã ã«è¬ã®ãŸãŸã
7
1,285
ClaudeããFable5ãšããæ°ã¢ãã«ã2æ¥åã«åºãŠãçæAIçéãããã€ããŠãããã©ãããã¯è¿çã®è³ªã段éãã«è¯ãã®ã§ã絶察ã«äœ¿ã£ãŠã¿ãæ¹ãè¯ãã
ãµãã¹ã¯ã§äœ¿ããã®ã¯6æ22æ¥ãŸã§ã§ã以éã¯apiã®ã¿ã1ãã£ããæ°çŸåããæ°ååã®è²»çšæã«ãªãã
3
8
2,449
ã©ããªãŒðçŒåœ¢æå€ç§å» retweeted
æ¥æ¬èªã®æžãç©ãããŠããŠæ°ä»ããããCellããå
¬éãããŠããäžåœã®å€§èŠæš¡èåç ç©¶ãããžã§ã¯ãã§ãæ¥æ¬ã®JOI registryãå
¬éããŠããçŒåºå¹Žéœ¢æšå®ã¢ãã«ãå©çšãããŠãããäžçã§ã®æŽ»çšãããã«é²ã¿ããã§æ¥œãã¿ïŒ
è«æïŒ
cell.com/cell/fulltext/S0092âŠ
幎霢æšå®ã¢ãã«ïŒ
joir.jp/data/index.html














